News | EuroPCR | May 05, 2020

EuroPCR Cancels Annual Meeting Due to COVID-19

EuroPCR Cancels Annual Meeting Due to COVID-19. #SARScov2 #COVID19

May 5, 2020 — The large European interventional cardiology conference EuroPCR has been cancelled due to the contenting containment efforts for COVID-19 (SARS-CoV-2).

"The sanitary and legal environment, and in particular the decisions of the French government barring public gatherings for events exceeding 5,000 participants, have resulted in us cancelling the EuroPCR 2020 Course in Paris as a consequence of the COVID-19 outbreak," stated a letter sent out by EuroPCR today from the EuroPCR Course Directors Andreas Baumbach, Alberto Cremonesi, Jean Fajadet and William Wijns.

They said over the last two to three months, the Paris Course on Revascularization (PCR) mission of sharing knowledge, experience and practice has remained more actively relevant than ever with multiple educational resources freely available on PCRonline.

The organizers of the meeting said they will be working with the program committee to provide a full update on late-breaking trials and other essential educational content. Details of the dates and platform to be used will be announced in the coming weeks.

"We reiterate our heartfelt solidarity to all those affected by the coronavirus across the globe and extend our warmest wishes for good health to you and your patients, colleagues and loved ones," the course directors said in the statement. 

For additional information on the status of EuroPCR. 

 

Related Cardiology Conference Cancellations Due to COVID-19:

Cardiology Meetings Continue to be Cancelled or Go Virtual Due to COVID-19

SCCT Plans to Make 2020 Annual Meeting Virtual Due to COVID-19

ACC Cancels 2020 Conference Amid Coronavirus Concerns

Heart Rhythm Society Cancels 2020 Meeting Due to COVID-19

European Heart Rhythm Association Cancelled Due to Coronavirus

 


Related Content

News | Coronavirus (COVID-19)

November 25, 2022 — A large study found that myocarditis after SARS-CoV-2 vaccination was rare but higher in younger ...

Home November 25, 2022
Home
News | Coronavirus (COVID-19)

November 10, 2022 — Researchers at the University of Maryland School of Medicine’s (UMSOM) Center for Precision Disease ...

Home November 10, 2022
Home
News | Coronavirus (COVID-19)

November 3, 2022 — In the past several years, myocarditis has been of public interest because of cases associated with ...

Home November 03, 2022
Home
News | Coronavirus (COVID-19)

November 2, 2022 — A comprehensive review and meta-analysis of published research confirm that young adults (40 years ...

Home November 02, 2022
Home
News | Coronavirus (COVID-19)

October 27, 2022 — New data analysis from the Smidt Heart Institute at Cedars-Sinai found that deaths from heart attacks ...

Home October 27, 2022
Home
News | Coronavirus (COVID-19)

October 17, 2022 — A national study suggests that risk factors for cardiovascular disease, such as age, smoking and ...

Home October 17, 2022
Home
News | Coronavirus (COVID-19)

September 26, 2022 — Kawasaki disease (KD) is the leading cause of acquired heart disease in children in developed ...

Home September 26, 2022
Home
News | Coronavirus (COVID-19)

September 7, 2022 — A new paper in European Heart Journal - Digital Health, published by Oxford University Press ...

Home September 07, 2022
Home
News | Coronavirus (COVID-19)

August 26, 2022 — COVID mRNA vaccines are associated with a decreased risk of death in patients with heart failure ...

Home August 26, 2022
Home
News | Coronavirus (COVID-19)

August 23, 2022 — In a detailed analysis of nearly 43 million people, ages 13 and older, who received at least one dose ...

Home August 23, 2022
Home
Subscribe Now